To test this hypothesis, we conducted a Next-Generation Sequencing (NGS) analysis and measured the methylation status of multiple CpG-rich subregions in the Septin9 promoter from CRC tumor tissues, compared with their paired adjacent normal tissues. The gene discussed is SEPTIN9; the disease is colorectal carcinoma.